XBiotech Inc.
XBIT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $4,010 | $18,394 |
| % Growth | – | -100% | -78.2% | – |
| Cost of Goods Sold | $0 | $0 | $651 | $5,820 |
| Gross Profit | $0 | $0 | $3,359 | $12,574 |
| % Margin | – | – | 83.8% | 68.4% |
| R&D Expenses | $37,757 | $32,848 | $31,544 | $28,268 |
| G&A Expenses | $4,714 | $4,662 | $6,305 | $9,388 |
| SG&A Expenses | $4,714 | $4,662 | $6,305 | $9,388 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $42,471 | $37,510 | $37,849 | $37,656 |
| Operating Income | -$42,471 | -$37,510 | -$34,490 | -$25,082 |
| % Margin | – | – | -860.1% | -136.4% |
| Other Income/Exp. Net | $3,908 | $13,197 | $902 | -$376 |
| Pre-Tax Income | -$38,563 | -$24,313 | -$33,588 | -$25,458 |
| Tax Expense | -$32 | $244 | -$688 | -$8,044 |
| Net Income | -$38,531 | -$24,557 | -$32,900 | -$17,414 |
| % Margin | – | – | -820.4% | -94.7% |
| EPS | -1.26 | -0.81 | -1.08 | -0.58 |
| % Growth | -55.6% | 25% | -86.2% | – |
| EPS Diluted | -1.26 | -0.81 | -1.08 | -0.58 |
| Weighted Avg Shares Out | 30,461 | 30,317 | 30,439 | 30,043 |
| Weighted Avg Shares Out Dil | 30,461 | 30,438 | 30,439 | 30,043 |
| Supplemental Information | – | – | – | – |
| Interest Income | $9,812 | $10,421 | $3,823 | $467 |
| Interest Expense | $807 | $0 | $0 | $0 |
| Depreciation & Amortization | $1,745 | $1,744 | $2,614 | $2,648 |
| EBITDA | -$36,011 | -$22,569 | -$31,876 | -$22,434 |
| % Margin | – | – | -794.9% | -122% |